top of page

NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML

Product details

Registration number: SIN16172P

Classification: Prescription Only

Active ingredients: Mepolizumab

Strength: 100mg/ml

Dosage form: INJECTION, SOLUTION

Route: SUBCUTANEOUS

Registrant: GLAXOSMITHKLINE PTE LTD

ATC code: R03DX09

HSA approval date: 27 April 2021

Manufacturer(s): Glaxo Operations UK Ltd (Trading as Glaxo Wellcome Operations)

Manufacturing country/countries: UNITED KINGDOM

What are the HSA registration number and classification for NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16172P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Mepolizumab

Strength: 100mg/ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION

Route: SUBCUTANEOUS

Source for this answer

Who is the recorded registrant for NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML?

According to the HSA dataset updated 7 August 2026:

Registrant: GLAXOSMITHKLINE PTE LTD

Source for this answer

Which manufacturers and countries are listed for NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Glaxo Operations UK Ltd (Trading as Glaxo Wellcome Operations)

Manufacturing country/countries: UNITED KINGDOM

Source for this answer

Where can I look up NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16172P or the exact product name NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16172P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page